Legislature(2015 - 2016)BUTROVICH 205

03/30/2016 01:30 PM HEALTH & SOCIAL SERVICES

Note: the audio and video recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.

Download Mp3. <- Right click and save file as
Download Video part 1. <- Right click and save file as

* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+= SB 113 NEW DRUGS FOR THE TERMINALLY ILL TELECONFERENCED
Moved CSSB 113(HSS) Out of Committee
+= SB 156 INSURANCE COVERAGE FOR CONTRACEPTIVES TELECONFERENCED
Moved CSSB 156(HSS) Out of Committee
*+ SB 179 BAN LATE TERM ABORTION; CHILD SURRENDER TELECONFERENCED
Heard & Held
+ Bills Previously Heard/Scheduled TELECONFERENCED
            SB 113-NEW DRUGS FOR THE TERMINALLY ILL                                                                         
                                                                                                                                
1:33:42 PM                                                                                                                    
CHAIR STEDMAN announced the consideration of SB 113.                                                                            
                                                                                                                                
1:34:33 PM                                                                                                                    
SENATOR BILL WIELECHOWSKI, Alaska  State Legislature, as sponsor,                                                               
introduced SB 113.  He termed SB 113 the "Right  to Try" bill. It                                                               
would create  a legal  climate in  which terminally  ill patients                                                               
who have  exhausted all FDA-approved  treatment options  may work                                                               
with   their   doctors   and   drug   manufacturers   to   access                                                               
investigational treatments  that have passed  Phase I of  the FDA                                                               
approval  process but  are not  yet widely  available. A  similar                                                               
bill has  been passed in 25  states. It is estimated  that over a                                                               
million  Americans die  from  terminal  illness. Currently,  only                                                               
about  3  percent are  accepted  into  clinical trials  and  have                                                               
access to these drugs.                                                                                                          
                                                                                                                                
SENATOR  STOLTZE  thanked  the  sponsor  for  answering  all  his                                                               
questions.                                                                                                                      
                                                                                                                                
1:36:07 PM                                                                                                                    
SENATOR  ELLIS  moved  to report  SB  113,  labeled  29-LS0783\H,                                                               
from committee with individual  recommendations and attached zero                                                               
fiscal note. There being no objection, the motion carried.                                                                      
                                                                                                                                

Document Name Date/Time Subjects
SB 156 - Updated Sectional for version N.PDF SHSS 3/30/2016 1:30:00 PM
SB 156
CSSB 156 version.N.PDF SHSS 3/30/2016 1:30:00 PM
SB 156
SB 156 - Letter of Support AK Pharmacists.PDF SHSS 3/30/2016 1:30:00 PM
SB 156
SB 156 - Letter in Support_Dr. Tina Tomsen, Anchorage Womens Clinic.pdf SHSS 3/30/2016 1:30:00 PM
SB 156
SB 156 - Letter of Support Barbara McDaniel.pdf SHSS 3/30/2016 1:30:00 PM
SB 156
SB 156 - Letter of Support Kachemak Bay Family Planning CLinic.pdf SHSS 3/30/2016 1:30:00 PM
SB 156
SB 156 - Letter of Support Pamela Jo Rahn.PDF SHSS 3/30/2016 1:30:00 PM
SB 156
SB 179 version W.PDF SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 - Sponsor Statement.PDF SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 - Ohio Senate.PDF SHSS 3/30/2016 1:30:00 PM
SB 179
SB 113 - Fiscal Note.PDF SHSS 3/30/2016 1:30:00 PM
SB 113
SB 156 Explination of Changes updated.PDF SHSS 3/30/2016 1:30:00 PM
SB 156
S B 179 - Leg. Legal opinion.pdf SHSS 3/30/2016 1:30:00 PM
SB 179 - Planned Parenthood memo.PDF SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 - Letter of Support.PDF SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 VIABLE CHILD PROTECTION ACT.pptx SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 American-Reports-Series-INTERNATIONAL-ABORTION-NORMS Feb 14.pdf SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 Guttmacher Institute_Overview of Abortion Laws.pdf SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 Guttmacher Institute_State Facts About Abortion.pdf SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 Premature Babies Survive at 22 weeks if Treated.pdf SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 Sectional for SB 179.pdf SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 Sponsor Statement.pdf SHSS 3/30/2016 1:30:00 PM
SB 179
Version W with Repealer Language.pdf SHSS 3/30/2016 1:30:00 PM
SB 179
SB 179 Letter of Opposition - Cyndy Cox.PDF SHSS 3/30/2016 1:30:00 PM
SB 179